Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.

by Vinod Vathipadiekal, Deepa Saxena, Samuel C Mok, Peter V Hauschka, Laurent Ozbun, Michael J Birrer
Published 2012-01-01

An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.

by Geetika Sethi, Harsh B Pathak, Hong Zhang, Yan Zhou, Margret B Einarson, Vinod Vathipadiekal, Sumedha Gunewardena, Michael J Birrer, Andrew K Godwin
Published 2012-01-01

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.

by Amanda Sosulski, Heiko Horn, Lihua Zhang, Caroline Coletti, Vinod Vathipadiekal, Cesar M Castro, Michael J Birrer, Osamu Nagano, Hideyuki Saya, Kasper Lage, Patricia K Donahoe, David Pépin
Published 2016-01-01

Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.

by Christopher K McCann, Whitfield B Growdon, Kashmira Kulkarni-Datar, Michael D Curley, Anne M Friel, Jennifer L Proctor, Hana Sheikh, Igor Deyneko, Jeanne A Ferguson, Vinod Vathipadiekal, Michael J Birrer, Darrell R Borger, Gayatry Mohapatra, Lawrence R Zukerberg, Rosemary Foster, John R Macdougall, Bo R Rueda
Published 2011-01-01

Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.

by Michael P Stany, Vinod Vathipadiekal, Laurent Ozbun, Rebecca L Stone, Samuel C Mok, Hui Xue, Takashi Kagami, Yuwei Wang, Jessica N McAlpine, David Bowtell, Peter W Gout, Dianne M Miller, C Blake Gilks, David G Huntsman, Susan L Ellard, Yu-Zhuo Wang, Pablo Vivas-Mejia, Gabriel Lopez-Berestein, Anil K Sood, Michael J Birrer
Published 2011-01-01